Outcomes research in head and neck oncology

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 4, Issue 2, 1996, Pages 73-77

  Deleyiannis, Frederic W B ^a   Weymuller Jr , Ernest A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RESEARCH; COST EFFECTIVENESS ANALYSIS; HEAD AND NECK CANCER; HUMAN; MEDICAL DECISION MAKING; ONCOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0029964597     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-199604000-00001     Document Type: Review

References (62)

1. Roper WL, Winkenwerder W, Hackbarth GM, Krakauer H: Effectiveness in health care. An initiative to evaluate and improve medical practice. N Engl J Med 1988, 319:1197-1202.
2. Epstein AM: The outcomes movement - will it get us where we want to go? N Engl J Med 1990, 323:266-270.
3. Marwick C: Federal agency focuses on outcomes research: medical news & perspectives. JAMA 1993, 270:164-165.
4. Maklan CW, Greene R, Cummings MA: Methodological challenges and innovations in patient outcomes research. Med Care 1994, 32:JS13-JS21.
5. Piccirillo JF: Outcomes research and otolaryngology. Otolaryngol Head Neck Surg 1994, 111:764-769.
6. Spitz MR, Sider JG, Schantz SP, Newell GR: Association between malignancies of the upper aerodigestive tract and uterine cervix. Head Neck 1992, 14:347-351.
7. Muir C, Weiland L: Upper aerodigestive tract cancers. Cancer 1995, 75:147-153. Study of survival, age-specific incidence rates, stage, site, and histology of the head and neck cancers reported to the SEER program of the US National Cancer Institute from 1973 to 1987.
8. Mitchell JB, Bubolz T, Paul JE, Pashos CL, Escarce JJ, Muhlbaier LH, Wiesman JM, Young WW, Epstein RS, Javitt JC: Using Medicare claims for outcomes research. Med Care 1994, 32:JS38-JS51.
9. Weis KA, Epstein RS, Huse DM, Deverka PA, Oster G: The costs of prostatectomy for benign prostatic hyperplasia. Prostate 1993, 22:325-334.
10. Guadagnoli E, Hauptman PJ, Ayanian JZ, Pashos CL, McNeil BJ, Cleary PD: Variation in the use of cardiac procedures after acute myocardial infarction. N Engl J Med 1995, 333:573-578.
11. Taplin SH, Barlow W, Urban N, Mandelson MT, Timlin DJ, Ichikawa L, Nefcy P: Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst 1995, 87:417-426. Demonstration of the effects of stage at diagnosis, age, and level of comorbidity on the costs of treatment of three types of cancer among members of a health maintenance organization.
12. Wasson JH, Cushman CC, Bruskewitz RC, Littenberg B, Mulley AG, Wennberg JE, and the Prostate Disease Patient Outcome Research Team: A structured literature review of treatment for localized prostate cancer. Arch Fam Med 1993, 2:487-493.
13. Powe NR, Tielsch JM, Schein OD, Luthra R, Steinberg EP for The Cataract Patient Outcome Research Team: Rigor of research methods in studies of the effectiveness and safety of cataract extraction with intraocular lens implantation. Arch Ophthalmol 1994, 112:228-238.
14. Neely JG: Literature review articles as a research form. Otolaryngol Head Neck Surg 1993, 108:743-748.
15. Thacker SB: Meta-analysis: a quantitative approach to research integration. JAMA 1988, 259:1685-1689.
16. L'Abbe KA, Detsky AS, O'Rourke K: Meta-analysis in clinical research. Ann Intern Med 1987, 107:224-233.
17. Stell PM: Adjuvant chemotherapy for head and neck cancer. Semin Radiat Oncol 1992, 2:195-205.
18. Munro AJ: An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995, 71:83-91. A meta-analysis demonstrating that the addition of chemotherapy to definitive standard treatment may improve survival for patients with head and neck cancer.
19. Snyderman CH, D'Amico F: Outcome of carotid artery resection for neoplastic disease: a meta-analysis. Am J Otolaryngol 1992, 13:373-380.
20. Woolley AL, Hogikyan ND, Gates GA, Haughey BH, Schechtman KB, Goldenberg JL: Effect of blood transfusion on recurrence of head and neck carcinoma: retrospective review and meta-analysis. Ann Otol Rhinol Laryngol 1992, 101:724-730.
21. Haughey BH, Gates GA, Arfken CL, Harvey J: Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992, 101:105-112.
22. Prasad S, Janecka IP: Efficacy of surgical treatment for squamous cell carcinoma of the temporal bone: a literature review. Otolaryngol Head Neck Surg 1994, 110:270-280.
23. Hassan SJ, Weymuller EA: Assessment of quality of life in head and neck cancer patients. Head Neck 1993, 15:485-496.
24. Browman GP, Levine MN, Hodson DI, Sathya J, Russell R, Skingley P, Cripps C, Eapen L, Girard A: The head and neck radiotherapy questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. J Clin Oncol 1993, 11:863-872.
25. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, Eckberg K, Lloyd S, Purl S, Blendowski C, Goodman M, Barnicle M, Stewart I, McHale M, Bonomi P, Kaplan E, Taylor S, Thomas CR, Harris J: The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993, 11:570-579.
26. Urken ML, Buchbinder D, Weinberg H, Vickery C, Sheiner A, Parker R, Schaefer J, Som P, Shapiro A, Lawson W, Biller HF: Functional evaluation following microvascular oromandibular reconstruction of the oral cancer patient: a comparative study of reconstructed and nonreconstructed patients. Laryngoscope 1991, 101:935-950.
27. Deleyiannis FW-B, Weymuller EA: Quality of life in patients with head and neck cancer. In Cancer of the Head and Neck, Third Edition. Edited by Myers EN, Suen JY. Philadelphia: WB Saunders, Co.; in press. A comprehensive review of QOL research methodology and results in head and neck cancer.
28. Doubilet P, Weinstein MC, McNeil BJ: Use and misuse of the term "cost effective" in medicine. N Engl J Med 1986, 314:253-256.
29. Detsky AS, Naglie IG: A clinician's guide to cost-effectiveness analysis. Ann Intern Med 1990, 113:147-154.
30. Weinstein MC: Cost-effective priorities for cancer prevention. Science 1983, 221:17-23.
31. American Medical Association Council on Scientific Affairs: Viability of cancer clinical research: patient accrual, coverage, and reimbursement. J Natl Cancer Inst 1991, 83:254-259.
32. Ettinger WH, Jr: Forces of change in the health care system: implications for cancer care in the 1990's. Cancer 1991, 67:1728-1731.
33. Smith TJ, Hillner BE, Desch CE: Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis. J Natl Cancer Inst 1993, 85:1460-1474.
34. Stell PM, Rawson NSB: Adjuvant chemotherapy in head and neck cancer. Br J Cancer 1990, 61:779-787.
35. Hoffman HT, Funk GF, McCulloch TM, Graham S: Cost analysis of treatment of oral cavity squamous cell carcinoma [abstract]. Otolaryngol Head Neck Surg 1995, 113:P50.
36. Miller MJ, Swartz WM, Miller RH, Harvey JM: Cost analysis of microsurgical reconstruction in the head and neck. J Surg Oncol 1991, 46:230-234.
37. Glenn MG, Komisar A, Laramore GE: Cost-benefit management decisions for carcinoma of the retromolar trigone. Head Neck 1995, 17:419-424.
38. Pauker SG, Kassirer JP: Decision analysis. N Engl J Med 1987, 316:250-258.
39. Sonnenberg FA, Roberts MS, Tsevat J, Wong JB, Barry M, Kent DL: Toward a peer review process for medical decision analysis models. Med Care 1994, 32:JS52-JS64. Presents a framework for a peer review process of decision models based on the collective experience of the members of the Inter-PORT Decision Modeling work group.
40. Plante DA, Piccirillo JF, Sofferman RA: Decision analysis of treatment options in pyriform sinus carcinoma. Med Decis Making 1987, 7:74-83.
41. Velanovich V: Choice of treatment for stage I floor-of-mouth cancer. Arch Otolaryngol Head Neck Surg 1990, 116:951-956.
42. Weiss MH, Harrison LB, Isaacs RS: Use of decision analysis in planning a management strategy for the stage NO neck. Arch Otolaryngol Head Neck Surg 1994, 120:699-702.
43. Piccirillo JF, Feinstein AR: Black-box mathematics and medical practice. Arch Otolaryngol Head Neck Surg 1993, 119:147-155.
44. Harrell FE, Lee KL, Matchar DB, Reichert TA: Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treat Rep 1985, 69:1071-1077.
45. Feinstein AR, Wells CK: A clinical-severity staging system for patients with lung cancer. Medicine 1990, 69:1-33.
46. Deleyiannis FW-B, Piccirillo JF, Kirchner JA: Relative prognostic importance of histologic invasion of the laryngeal framework by hypopharyngeal cancer. Ann Otol Rhinol Laryngol 1996, 105:101-108.
47. Piccirillo JF: Purposes, problems, and proposals for progress in cancer staging. Arch Otolaryngol Head Neck Surg 1995, 121:145-149. Identification of the problems with the current TNM cancer classification system and recommendations for improvement.
48. Snyderman CH, Wagner RL: Superiority of the T and N integer score (TANIS) staging system for squamous cell carcinoma of the oral cavity. Otolaryngol Head Neck Surg 1995, 112:691-694.
49. Weymuller EA, Ahmad K, Casiano RR, Schuller D, Scott CB, Laramore G, Al-Sarraf M, Jacobs JR: Surgical reporting instrument designed to improve outcome data in head and neck cancer trials. Ann Otol Rhinol Laryngol 1994, 103:499-509.
50. Linn BS, Robinson DS, Klimas NG: Effects of age and nutritional status on surgical outcomes in head and neck cancer. Ann Surg 1988, 207:267-273.
51. McGuirt WF, Davis SP: Demographic portrayal and outcome analysis of head and neck cancer surgery in the elderly. Arch Otolaryngol Head Neck Surg 1995, 121:150-154.
52. Kokoska MS, Piccirillo JF, Haughey BH: Gender differences in cancer of the larynx. Ann Otol Rhinol Laryngol 1995, 104:419-424.
53. Katz AE: Immunobiological staging of patients with carcinoma of the head and neck. Laryngoscope 1983, 93:445-461.
54. Katz AE: Update on immunology of head and neck cancer. Med Clin North Am 1993, 77:625-631.
55. Feinstein AR: Symptoms as index of biological behaviour and prognosis in human cancer. Nature 1966, 209:241-245.
56. Piccirillo JF, Wells CK, Sasaki CT, Feinstein AR: New clinical severity staging system for cancer of the larynx: five-year survival rates. Ann Otol Rhinol Laryngol 1994, 103:83-92.
57. Kaplan MH, Feinstein AR: The Importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 1974, 27:387-404.
58. Charlson ME, Pompei P, Ales HL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987, 40:373-383.
59. Mick R, Vokes EE, Weichselbaum RR, Panje WR: Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy. Otolaryngol Head Neck Surg 1991, 105:62-73.
60. Fountzilas G, Kosmidis P, Beer M, Sridhar KS, Banis K, Vritsios A, Daniilidis J: Factors influencing complete response and survival in patients with head and neck cancer treated with platinum-based induction chemotherapy. Ann Oncol 1992, 3:553-558.
61. Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, Skingley P, Levine MN: Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 1993, 328:159-163.
62. Stevens MH, Gardner JW, Parkin JL, Johnson L: Head and neck cancer survival and life-style change. Arch Otolaryngol 1983, 109:746-749.